Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Glial influences on BBB functions and molecular players in immune cell trafficking.
Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats.
Duality of Antidepressants and Neuroprotectants.
Translation, Cultural Adaptation and Validation of the Qualiveen-30 Questionnaire in Persian for Patients with Spinal Cord Injury and Multiple Sclerosis.
Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis.
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Sleep Disorders in Multiple Sclerosis.
Schwann cells-axon interaction in myelination.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
Gut commensalism, cytokines, and central nervous system demyelination.
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
[Locomotive syndrome and Frailty. Vitamin D and Frailty].
Expanding the differential diagnosis of inherited neuropathies with non-uniform conduction: Andermann syndrome.
Progression of Relapsing-Remitting Demyelinating Disease Does Not Require Increased TCR Affinity or Epitope Spread.
The proline-rich region of 18.5-kDa myelin basic protein binds to the SH3-domain of Fyn tyrosine kinase with the aid of an upstream segment to form a dynamic complex in vitro.
Subjective cognitive fatigue in multiple sclerosis depends on task length.
bFGF Protects Pre-oligodendrocytes from Oxygen/Glucose Deprivation Injury to Ameliorate Demyelination.
Pages
« first
‹ previous
…
625
626
627
628
629
630
631
632
633
…
next ›
last »